Search results for "diffuse large B-cell lymphoma"

The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a cure.
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name: anbalcabtagene autoleucel) was deemed...
Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone

Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone

For patients with aggressive blood cancers that recur or fail to respond to standard chemotherapy, chimeric antigen...